Brain Disorders 2023 | Prague | Czech Republic | Allied Conferences | Meetings

Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academies Conferences

Theme

Exploring the Future of Brain Health

- Brain Disorders 2023

Welcome Message

We cordially welcome and invite all Keynote speakers, speakers, delegates, students, exhibitors and sponsors from across the world to participate in the”10thInternational Conference on Brain Disorders and Therapeutics” which is scheduled to be held from May 11-13, 2023 in Prague, Czech Republic.

Brain Disorders 2023 is best opportunity to attend the world's largest gathering of people to join, give lectures, share experiences, and network with present and future scientists to gain knowledge more about in the field of neurology, neuroscience, central nervous system, neuropharmacology, and neurodegenerative diseases, and to make a significant impact.

The mission of the Brain Disorder conference is to enhance treatment for brain and brain disorders, expedite the interpretation of front-line disclosure at the clinical level, and advance global logical collaboration, discussion, and commerce.

This is a great opportunity for the delegates to interact with world-class experts, scientists, and researchers. The interested participants can confirm their participation by registering for the Brain Disorders 2023 along with your colleagues. This Conference will provide an excellent forum for leading scientists, business leaders, and investors in this exciting field to exchange ideas and authoritative world views.

We really anticipate seeing you at Brain Disorders 2023 with all the other scholars in the field. You will undoubtedly have a fantastic time with all the other scholars.

Come together to explore Prague, Czech Republic!

Regards,
Organizing Committee
Brain Disorders 2023

Market Analysis

Brain disorders are the leading cause of death worldwide. It is defined as disorders of both the central and peripheral nervous systems. Congenital neurological abnormalities manifest themselves during the early stages of embryo development and are detectable at birth. A variety of factors, including traumatic brain injuries, immunological issues, postnatal injections, brain surgery, spinal cord injuries, neoplasia, and environmental chemicals or poisons, can result in unacquired neurological disorders after birth. Many bacterial, viral, fungal, and parasitic diseases can harm the nervous system and cause neurological disorders.

The global Brain Disorders were worth $383.31 billion in 2020 and is expected to grow to $ 537.97 billion by 2030, with a CAGR of 3.5 percent from 2021 to 2030. The absence of a positive feeling, neurological disorders, Therapeutics, and a variety of related cognitive, physical, emotional, and behavioral indicators are all signs of mental health issues. It could be a very common disease that affects one out of every five people. Sadness is caused by a number of factors, including personality, stress, and brain surgery. According to the World Health Organization, more than 264 million people of alleges that will be discouraged by 2020. Disappointment may be a driving cause of inability all over the world, contributing to the overall global inability.

According to the most recent WHO survey, Neurological Disorders which include Parkinson’s, Stroke, Alzheimer's disease and Dementia, Epilepsy, and many others, account for more than 12% of deaths worldwide on average. It is also predicted that the number of disability-adjusted life years lost due to Neurological Disorders will increase from 95 million in 2015 to 103 million by 2030. Furthermore, the global cost of neurological squeal solitary was estimated in 2010 to be US$ 2.5 trillion, with the value expected to rise to more than US$ 6 trillion by 2030.

Market Value on Brain Disorders Research:

The neurological disorders drugs market was valued at USD 79.40 billion in 2021 and is expected to reach USD 125.60 billion by 2029, growing at a CAGR of 5.9% from 2022 to 2029. According to the Traumatic Brain Injury monitoring market analysis, North America will be the largest region in 2021. During the forecast period, Asia-Pacific is expected to be the fastest-growing region in the global brain monitoring market. Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa are the regions covered in the global brain monitoring industry outlook.

The neurological disorders drugs market is expected to grow as a result of rising awareness associated with early disease diagnosis through awareness campaigns by government regulatory bodies and private organizations, as well as the imminent market entry of efficient drugs due to the presence of a strong drug pipeline. According to a report released in April 2018 by the Pharmaceutical Research and Manufacturers of America(PhRMA), biopharmaceutical companies in the United States are currently developing 537 medications for a variety of neurological disorders. Among the mare 95 drugs for brain tumors, 46 for chronic pain, and 92 for Alzheimer's disease. Among the 30 illnesses being studied are multiple sclerosis, migraines, amyotrophic lateral sclerosis, and Parkinson's disease.

Recent Development on Brain Disorders:

The study of brain and assisting in the treatment of various brain disorders and diseases has been made possible by contemporary technological advancements in portable technologies. The burden of brain dysfunction and neurological disorders, as well as the demand for medical resources, are anticipated to rise over time, according to BMJ Publishing Group Ltd. The global population of adults aged 60 and up is predicted to reach 2 billion by 2050.

Accordingly, there will be a significant increase in demand for treatment, rehabilitation, and support services for neurological conditions like Parkinson's disease, Alzheimer's disease, schizophrenia, depression, and other dementias in the coming decades. Furthermore, thanks to recent developments in brain imaging technology, the brain, and its functions can now be seen in high resolution. For instance, near-infrared functional spectroscopy is a non-invasive imaging method that makes use of variations in hemoglobin light absorption patterns to estimate the relative concentration of hemoglobin in the brain.

Products manufactured by the industry related Brain Disorders Research and its Market value

According to the WHO, approximately 50 million people worldwide have brain disorders like dementia, epilepsy, and sleep disorders with approximately 10 million new cases reported each year. Furthermore, the Psychiatric Disorders Association estimates that approximately 13.8 million people aged 65 and up will suffer from Alzheimer's dementia by 2050. Alzheimer's disease and dementia are expected to affect approximately 5.8 million people in the United States aged 65 and up in 2023.

The global brain monitoring market is divided into product segments such as magnetoencephalography, electroencephalographs, cerebral oximeters, functional magnetic resonance imaging (fMRI), intracranial pressure monitoring devices, and others; procedure segments such as invasive, non-invasive application segments such as Parkinson's disease, traumatic brain injury, epilepsy, dementia, sleep disorders, and others; and end-user segments such as hospitals and clinics, neurology centers, ambulatory surgery centers, and others.

The rapidly increasing prevalence and incidence of neurological disorders will drive the growth of the brain surgery monitoring market in the coming years. Brain monitoring is the use of instrumentation to track the progression of a neurologic injury. In neurological disorders, brain monitoring is used to improve the accuracy and reliability of information about the severity of the neurologic injury. According to a World Health Organization (WHO) report, the global prevalence of neurological health problems is expected to reach nearly 103 million by 2030. As a result, the growing incidence and prevalence of neurological disorders are driving the growth of the brain monitoring market.

The brain surgery health supplement market is characterized by an increasing number of product launches in response to the growing demand for high-quality supplements to support and maintain brain health, improve memory, and improve brain function. For example, Cosmos Holdings, an international pharmaceutical company, announced the launch of its luxury nutritional supplement product line - 'Brain lit' for brain health- in March 2022. As the prevalence of brain-related conditions such as Alzheimer's, dementia, Parkinson's, depression, and anxiety has increased in recent years, the company's R&D team created an advanced formula to support and enhance brain function.

Major Associations around the Globe

Brain injury association of America
Neuropathy Association
The brain & behavior research foundation
Alzheimer's Association

Associations of Brain disorders are there in the UK

Brain injury association
BritishNeuroscience Association
Brain tumor charity
Brain& Spine Foundation
BritishNeuro-Oncology Society
BrainInjury Association of London
StrokeAssociation
BrainInjury Rehabilitation Trust
RoyalSociety of London
Alzheimer'sSociety
MigraineTrust
InternationalHeadache Society
Huntington's-disease Association
Brain tumor organizations
NationalBrain Tumor Society
British neuroscience association
British brain tumor association
ScottishAssociation for Mental Health
Association for Infant Mental Health
NationalAssociation for Mental Health

About Conference

Despite the efforts of the Brain Disorders 2023 organizing committee, we delighted to extend an invitation to you to the “10th International Conference on Brain Disorders and Therapeutics”, which will be held in Prague, Czech Republic on May 11-13,2023.The goal of Brain Disorders 2023 is to bring together all of the world's finest scientists, intellectuals, and researchers' ideas in the field of healthcare.

Brain Disorders 2023 encourages participants from all top academic institutions and clinical research labs to share their research on all facets of this quickly expanding subject, meet with top researchers, and display the most recent methods. This conference will primarily concentrate on the most recent and exciting advancements in neuroscience research, and it will increase the opportunity for experts from around the world to interact scientifically.

You would want to look forward to

Admirable keynote presentations
Enlightening plenary lectures
Informatory poster and video presentations
Enriching workshops
Innovative exhibitions

Who should attend?

With members from all over the world interested in learning about Brain Disorders and its advancements, this is your best chance to reach the most people in the Neurological Community. At this two-day event, you can give presentations, distribute information, meet with current and potential scientists, make a splash with new discoveries in neurosurgical treatment and diagnosis, and gain name recognition. This conference features world-renowned speakers, the most recent techniques, developments, and the most recent updates in the field of Neurosurgery and its various treatments such as Brain Disorders, Neuroplasticity, Endovascular Techniques, Neuro Physiotherapy, NIDS, Key-hole Brain Surgery, Craniotomy, Neuro-Endoscopy, Neuro-Pharmacology, Neuro-Traumatic Brain Injuries, Treatment for Neuro-Ophthalmologic Disorders, and Robotic Neurosurgery.

Neuro-oncologist
Neurologist
Physiatrist
Rehabilitation therapist
Physician
Professor’s
Researchers
Intellectuals
Students
Research scholars
Intellectuals CEOs, directors of organizations

Neurologists, neurooncologists, psychiatrists, rehabilitation therapists, professors, doctors, research scholars and students. Business professionals and CEO’s and R&D Heads of industries are promised a very productive experience in expanding your network as well as resources.

We welcome anyone who would like to make the best out of this amazing networking opportunity.

Past Conference Report:

We would like to thank all of our notable dignitaries for presenting us with the wonderful keynotes, speakers, congress attendees, students, associations, media partners, and guests for making Brain Disorders Conference 2022 a successful and splendid event.

Allied Academies hosted the event of the 9th International Congress on Brain Disorders and Therapeutics during February28-29, 2022 at Holiday Inn Rome Aurelia, Rome, Italy with the theme Exploring the destiny of Brain Health. Benevolent response and active participation were received from the Editorial Board Members of supporting International Journals as well as from the leading academic scientists, researchers, research scholars, students, and leaders from the fields of Neurology, Neuroscience, Psychiatric, and Brain Dynamic who made this event successful.

The congress was marked by the attendance of young and brilliant researchers, business delegates, and talented student communities representing more countries, who have driven this event into the path of success. The congress was highlighted through various sessions on Brain Disorders research.

Brain Disorders Congress 2023 witnessed an amalgamation of peerless speakers who enlightened the crowd with their knowledge and confabulated on various new-fangled topics related to the fields of Brain Injury, Stroke, psychology, and Brain Dynamic.

The meeting was carried out through various sessions, in which the discussions were held on the following major scientific tracks:

Brain Disorders
Stroke
Neurodegenerative Disorders
Psychology
Neuro-ophthalmology

The congress proceedings were carried out through various Scientific-sessions and plenary lectures. The congress was embarked with an opening ceremony followed by a series of lectures delivered by both Honorable Guests and members of the Keynote forum. The adepts who promulgated the theme with their exquisite talk and testimonials received from the keynote speakers and workshop were;

The event enlightened various areas of Brain Disorders with workshops and plenary lectures from the speakers of various universities and organizations like:

We are also obliged to various delegate experts, company representatives, and other eminent personalities who supported the congress by facilitating active discussion forums. We sincerely thank the Organizing Committee Members for their gracious presence, support, and assistance towards the success of Brain Disorders Congress 2022.With the grand success of Brain Disorders Congress 2022, we are proud to announce the "10th International Conference on Brain Disorders and Therapeutics” to be held on May 11-13, 2023 at Prague, Czech Republic.

Sessions & Tracks

Session on: Brain and Brain Disorders

The Brain Disorders drugs market was valued at USD 79.40 billion in 2021 and is expected to reach USD 125.60 billion by 2029, growing at a CAGR of 5.9% from 2022 to 2029. The prevalence of Brain Disorders is rising globally due to an ageing population and an average lifespan. The need for diagnostic tools has increased recently due to an increase in the prevalence of neurological disorders. Increased awareness, an increase in the prevalence of neurological disorders, and a robust product pipeline for the treatment of Neurorehabilitation are the main drivers of market growth. 533,172 people died from neurological conditions in 2019, of whom 320,043 (60%) were women and 213,129 (40%) were men. The market for Brain Disorders is expected to expand as a result of the burden of neurological disorders, which will increase demand for treatments and efficient treatment options.

Related Associations:

Brain Injury Association of America | United Brain Association | Brain Injury Association of Rhode Island | American Bechet's Disease Association and American BrainCoalition | Brain Tumor Research and Information | Brain Injury Resource Center and Brain Trauma Foundation | Childhood Brain Tumor Foundation |American Brain Tumor Association and American Cancer Society | Migraine Research Brain Disorders Conference Foundation | National Parkinson Foundation | International Brain Injury Association| International Brain Research Organization | World Federation of Neurology and Brain Disorders Conferences

Associated Conferences:

Associated Journals:

Associated Societies:

Committee of Neuroscience National Societies | Interdisciplinary Symposium on Neuroscience Congress | British Pediatric Neurology Association | Bhopal Intellectual progressive educational society of Neuroscience conference (BIPES) | Norwegian Brain Disorder Conference Society | Clinical Neuroscience Society (ECNS)

Session on: Brain tumors

The market treating brain tumors worldwide had a market value of US$ 2,946.17 million in 2022, and it is anticipated to reach US$ 5,904.82 million by 2032, growing at a CAGR of 7.2%. Key factors that are anticipated to foster the growth of the brain tumor diagnosis market globally include the rising prevalence of such cancer and the expanding geriatric population. The global demand for brain surgery treatment is anticipated to grow at a CAGR of 7.2%between 2022 and 2032, reaching a total of US$ 5,904.82 Million in 2032. (FMI).Sales increased significantly between 2017 and 2021, with a 6.8% CAGR.

Related Associations:

Associated Conferences:

Associated Journals:

Associated Societies:

Functional Neurological Disorder Society | Interdisciplinary Symposium on Neuroscience Congress | Functional Neurological Disorder Society | Bhopal Intellectual progressive educational society of Neuroscience conference (BIPES) | | Clinical Neuroscience Society(ECNS)

Session on: Stroke

The global market for stroke diagnostic and therapeutic products was estimated to be worth USD 32.69 billion in 2021 and is expected to reach USD 65.45 billion by 2030, growing at a projected CAGR of 8% from 2022 to2030. Expanding geriatric populations and rising Neuroscience disease rates will be the main factors driving the stroke management market. Over 70 years old made up 56% of aortic valve stenosis patients in Europe. Additionally, a number of government agencies have started awareness campaigns to lower the frequency of strokes and brain disorders among the elderly population. For instance, the Patient Protection and Affordable Care Act (ACA) in the United States provides health coverage to more than 20 million people, including senior citizens.

Related Associations:

Brain Injury Association of America | United Brain Association | Brain Injury Association of Rhode Island | American Bechet's Disease Association and American BrainCoalition | Brain Tumor Research and Information | American Brain Tumor Association and American Cancer Society | Migraine Research Brain Disorders Conference Foundation | National Parkinson Foundation | International Brain Injury Association| International Brain Research Organization | World Federation of Neurology and Brain Disorders Conferences| World Federation of Neurology and Brain Disorders Conferences | Migraine Research Brain Disorders Conference Foundation | Association of Brain Disorders Conference Scientists

Associated Conferences:

Associated Journals:

Journal of Molecular Neuroscience | Current Neurology and Neuroscience Reports | Journal of Neurophysiology | Journal of Molecular Neuroscience |Journal of Psychiatry and Neuroscience Journal of Brain Disorders and Neurosurgery

Associated Societies:

International Parkinson and Movement Disorder Society | Interdisciplinary Symposium on Neuroscience Congress | Functional Neurological Disorder Society | Bhopal Intellectual progressive educational society of Neuroscience conference (BIPES) | Norwegian Brain Disorder Conference Society

Session on: Parkinson’s Disease

The size of the global Parkinson's disease treatment market was estimated at USD 4.28 billion in2021, and it is anticipated to increase at a CAGR of 12.1% from 2022 to 2030.The growth for treatments for Parkinson's disease was valued at USD 4.28 billion in 2021, and from 2022to 2030, it is projected to grow at a CAGR of 12.1%. In addition, a significant market trend for Parkinson's disease that is supporting the industry's expansion is a strong pipeline of new drug development. In the US, there are almost 1 million people with Parkinson's disease.

Related Associations:

Associated Conferences:

Associated Journals:

Associated Societies:

Committee of Neuroscience National Societies | Interdisciplinary Symposium on Neuroscience Congress | Japanese Society of Neurology | Bhopal Intellectual progressive educational society of Neuroscience Conferences (BIPES) The British Neuroscience Association| Chinese Society for Neuroscience | German Neuroscience Society | International Behavioral Neuroscience Society(IBNS)|EEG and Clinical Neuroscience Society (ECNS) | Cognitive Neuroscience Society(CNS) | Norwegian Neuroscience Society (NTNU) | Federation of Neuroscience Societies of Latin America and the Caribbean (FALAN).

Session on: Alzheimer’s Disease

The size of the global market for Alzheimer's therapeutics was estimated at USD 4.04 billion in 2021, and it is anticipated to grow at a CAGR of 16.2% from 2022 to 2030. Market expansion is anticipated to be fueled by the increasing prevalence of Alzheimer's disease and the approval of disease-modifying treatments. Alzheimer's disease was present in about 6.2 million Americans 65 and older in 2021; by 2060, that number is expected to rise to about 13.8 million. Due to their longer life expectancy, women are more likely than men to be diagnosed with Alzheimer's disease. Additionally, Alzheimer's disease is quickly over taking other neurodegenerative diseases as the leading cause of death and a major contributor to physical impairment that calls for urgent medical attention.

Related Associations:

Brain Injury Association of America | United Brain Association | Brain Injury Association of Rhode Island | American Behcet's Disease Association and American BrainCoalition | Brain Tumor Research and Information | Brain Injury Resource Center and Brain Trauma Foundation | Childhood Brain Tumor Foundation |American Brain Tumor Association and American Cancer Society | Migraine Research Brain Disorders Conference Foundation | National Parkinson Foundation | International Brain Injury Association| International Brain Research Organization | World Federation of Neurology and Brain Disorders Conferences| World Federation of Neurology and Brain Disorders Conferences | Migraine Research Brain Disorders Conference Foundation | Association of Brain Disorders Conference Scientists

Associated Conferences:

Associated Journals:

Journal of Brain and Neurology | Current Opinion in Neurology | European Journal of Neuroscience |European Journal of Preventive Neuroscience in Oxford Academic |Journal of Comparative Neurology

Associated Societies:

Annals of the Child Neurology Society | Committee of Neuroscience National Societies | Interdisciplinary Symposium on Neuroscience Conferences | Japanese Society of Neurology | Bhopal Intellectual progressive educational society of Neuroscience Conference(BIPES) | Brain Disorders Research Society of Finland | Society for Neuroscience| The Social and Affective Neuroscience Society | Interdisciplinary Symposium on Neuroscience Conferences

Session on: Dementia

The market for treatments for dementia was valued at USD 13,459.39 million in 2021, growing at a CAGR of 8.28% during the anticipated period 2022 - 2027. The market for dementia medications is anticipated to be significantly impacted by theCOVID-19 pandemic outbreak. The market for dementia drugs is likely to grow as a result of the ageing population suffering from a variety of disorders and the rising prevalence of target disorders. The increasing incidence of dementia cases is one of the main factors influencing the global market for drugs to treat it. Alzheimer's Disease International estimates that there will be more than50 million dementia sufferers worldwide in 2020. This number is anticipated to double every 20 years, rising to 82 million in 2030 and 152 million in 2050.

Related Associations:

Associated Conferences:

Associated Journals:

Behavioral and Brain Sciences | Journal of Clinical Neuroscience | Journal of Comparative Neurology |European Journal of Preventive Neuroscience in Oxford Academic |Frontiers in Neuroendocrinology

Associated Societies:

Brain Disorders Research Society of Finland | Society for Neuroscience| The Social and Affective Neuroscience Society | The British Neuroscience Association | Chinese Society for Neuroscience| German Neuroscience Society | International Behavioral Neuroscience Society(IBNS)|EEG and Clinical Neuroscience Society (ECNS) | Cognitive Neuroscience Society(CNS) | Norwegian Neuroscience Society (NTNU) | Federation of Neuroscience Societies of Latin America and the Caribbean (FALAN).

Session on: Traumatic Brain Injury

The market for traumatic brain injury assessment and management tools were estimated to be worth USD 2.89 billion in 2021, and it is anticipated to expand at a CAGR of 7.5% from 2022 to 2030. The main factors anticipated to propel the growth of the traumatic brain injuries (TBIs) assessment and management devices market is the rising prevalence of TBIs, rising patient preference for minimally invasive procedures, as well as increased awareness regarding brain injury treatment.

Related Associations:

Associated Conferences:

Associated Journals:

Associated Societies:

Canadian Neurological Society| Committee of Neuroscience National Societies | Interdisciplinary Symposium on Neuroscience Congress | Saudi Neurology Society| Bhopal Intellectual progressive educational society of Neuroscience conference (BIPES) | Chinese Society for Brain Disorder Conference| Society for German Brain Disorder Conference

Session on: Diagnosis of Brain Disorder

The growth for Brain disorders diagnostics is anticipated to reach US$12,162.6 million in 2019 and grow at a7.6% CAGR during the forecast period (2019–2027). Tools for diagnosing neurological disorders include medical equipment for conditions like Alzheimer's disease (AD), Parkinson's disease (PD), and multiple sclerosis. Imaging tools like computed tomography (CT), magnetic reason acne imaging (MRI), and in vitro diagnostic tools like biomarkers and biopsy are among the devices that are primarily used in diagnosis. The need for diagnostic tools has increased recently due to an increase in the prevalence of neurological disorders. For instance, the Alzheimer's Association reported in 2018 that 5.7 million Americans across all age groups experienced dementia and Alzheimer's in 2017.

Related Associations:

Associated Conferences:

Associated Journals:

Associated Societies:

Brain Disorders Research Society of Finland | Society for Neuroscience| The Social and Affective Neuroscience Society | Society for Neuroscience | Interdisciplinary Symposium on Neuroscience Conference | Canadian Neurological Society | Bhopal Intellectual progressive educational society of Neuro science conference (BIPES) | Chinese Society for Brain Disorder Conference| Society for German Brain Disorder Conference

Session on: Psychiatric Disorders

The size oft he global market for mental health and Neurorehabilitation was US$ 381.98 billion in 2020; it is projected to grow to US$ 527.44 billion by 2030, at a CAGR of 3.40 percent. The global mental health market is divided into sections based on region, age group, disorder, and service. With a projected CAGR of 3.5% from 2021 to 2030, the global market for mental health is expected to grow from its estimated value of $383.31 million in 2020 to$537.97 million by 2030.

Related Associations:

Associated Conferences:

Associated Journals:

Associated Societies:

Behavioral Neuroscience Society(IBNS) | EEG and Clinical Neuroscience Society (ECNS) | Cognitive Neuroscience Society (CNS) | Norwegian Neuroscience Society (NTNU) | Committee of Neuroscience National Societies | Interdisciplinary Symposium on Neuroscience Conference | Canadian Neurological Society |Bhopal Intellectual progressive educational society of Neuroscience conference (BIPES)

Session On: Neurodegenerative and Aging

The market for neurodegenerative diseases is projected to grow at a CAGR of 7% over the course of the forecast period, from US$ 43.7 Bn in 2021 to US$ 92 Bn by 2032. Due to the rising prevalence of neurological diseases, an ageing population, and rising treatment demand for Alzheimer's and Parkinson's disease, the market for neurodegenerative diseases is anticipated to exhibit promising growth prospects during the period of fore casting.

Related Associations:

Associated Conferences:

Associated Journals:

Associated Societies:

Committee of Neuroscience National Societies | Interdisciplinary Symposium on Neuroscience Congress | Canadian Neurological Society | Bhopal Intellectual progressive educational society of Neuroscience conference (BIPES) | Chinese Society for Brain Disorder Conference| Society for German Brain Disorder Conference

Session on: Spine andSpinaldisorders

The market for spine disorders implants and devices were estimated to be worth USD12.4 billion in 2021, and from 2022 to 2030, it is anticipated to grow at ac ompound annual growth rate (CAGR) of 5.1%. The increase in spinal cord injuries (SCIs) worldwide is responsible for the market growth. Damage to the spinal cord and Neuroscience results from compression or injury on the outside of the cord. The primary causes of this compression are either spinal degeneration, bone fractures, or anomalies like hematomas or herniated discs.

Related Associations:

Brain Injury Association of America | United Brain Association | Brain Injury Association of Rhode Island | American Behcet's Disease Association and American BrainCoalition | Brain Tumor Research and Information | Brain Injury Resource Center and Brain Trauma Foundation | Childhood Brain Tumor Foundation |American Brain Tumor Association and American Cancer Society | Migraine Research Brain Disorders Conference Foundation | National Parkinson Foundation | International Brain Injury Association| International Brain Research Organization | World Federation of Neurology and Brain Disorders Conferences World Federation of Neurology and Brain Disorders Conferences | Migraine Research Brain Disorders Conference Foundation | Association of Brain Disorders Conference Scientists

Associated Conferences:

AssociatedJournals:

AssociatedSocieties:

Session on: Neurosurgery

The annual growth rate (CAGR) of 15.4%, the market for devices and equipment used in brain surgery and brain disorders increased from $6.22 billion in 2021 to $7.18 billion in 2022. At least temporarily, the Russia-Ukraine conflict hampered the chances of a COVID-19 pandemic-related global economic recovery. Economic sanctions against several nations, a rise incommodity prices, and disruptions in the supply chain as a result of the conflict between these two nations have all had an impact on numerous markets around the world. At a CAGR of 11.9%, the market for neurosurgery instruments and supplies is anticipated to reach $11.27 billion in 2026.

Related Associations:

Associated Conferences:

Associated Journals:

Associated Societies:

Session on: Muscular Dystrophy

Muscle degeneration caused by the genetic disorder Duchenne Muscular Dystrophy (DMD), which is X-linked recessive. However, it canals be passed down from parents or be the result of a recent mutation. Although there are numerous treatments and medications to manage DMD, there is still no known cure for the disease. The market for muscular dystrophy was valued at USD 693.34 million in 2021, and by2028, it is anticipated to have grown to USD 1,533.72 million, with a CAGR of more than 11.87%. (2022–2028).

Related Associations:

Associated Conferences:

Associated Journals:

Associated Societies:

Session on: Pediatric Neurology

Pediatric neurology refers to a technical branch of drug that deals with the opinion and operation of neurological conditions in babes(babe), babies, children, and adolescents. Pediatric neurology, sometimes known as child neurology, is the study of brain, spinal cord, peripheral nerve, and muscle conditions that affect newborns, kids, and teenagers. Join us at Brain Disorders 2023 to learn more.

Related Societies: International Neuroscience Conference Society(INS) | International Neuroinformatic Coordinating Facility (INCF) |International Society for Invertebrate Neurobiology (ISIN) | International Society of Neuropathology (ISN) | International Society of Psycho neuroendocrinology (ISPNE) | International Union of Physiological Sciences (IUPS) | Association pour la Promotion des Neurosciences (APRONES)| Kenya Society for Neurosciences| Mediterranean Neuroscience Society

Session on: Down syndrome

Down syndrome is a condition in which a person has a redundant chromosome. Chromosomes are small “packages” of genes in the body. They determine how a baby's body forms and functions as it grows during gestation and after birth. Normally, a baby has born with 46 chromosomes.

Session on: Multiple Sclerosis

Multiple sclerosis is a chronic complaint that affects the central nervous system, which is the brain, spinal cord, and optical nerves. This can lead to a wide range of symptoms throughout the body. Scientists don't know exactly what causes Multiple Sclerosis, but they believe Trusted Source it's an autoimmune complaint that affects the Central Nervous System (CNS). When a person has an autoimmune complaint, the immune system attacks healthy tissue, just as it might attack a contagion or bacteria.

Session on: Neuropsychology

Neuropsychology is the discipline which investigates the relations between brain disorders conferences processes and mechanisms on one hand, and cognition and behavioral control on the other. Neuropsychology is a branch of psychology. It's concerned with how a person's cognition and behavior are related to the brain and the rest of the nervous system. Professionals in this branch of psychology frequently concentration how injuries or illnesses of the brain affect cognitive and behavioral functions.

Related Associations:

Associated Conferences:

Associated Journals:

Associated Societies:

Organizing committee members

Dr. Ian Martins

Professor, Neuroscience

Edith Cowan University, Australia

Ching-Kuan Liu

President, Neuroscience

Neurology Kaohsiung Medical University, Taiwan

Radu MUTIHAC

Professor, Neuroscience

Emeritus University of Bucharest, Romania

Robert Buckingham

Professor, Neuroscience

Santa Barbara Cottage Hospital, USA

Dario Furnari

Professor, Neuroscience

University of Exeter, UK

Renowned Speakers

David J. Dickoff

Assistant clinical professor, Neuroscience

The Mount Sinai Hospital New York, USA

Hadi Eltonsi

Cairo University, Egypt

Dr. Segundo Mesa Castillo

Doctor, Neurology

National Institute of Health, Algeria

Tzung-Yan Lee

Professor, Neuroscience

Chang Gung University, Taiwan

Joanna B Strosznajder

Professor, Neuroscience

Polish Academy of Sciences, Poland

To Collaborate Scientific Professionals around the World

Conference Date	May 11-13, 2023
Poster Oppurtunity	Available
e-Poster Oppurtunity	Available

Testimonials

Owen J Connolly

Owner & Senior Counselling Psychologist, Ireland

I wanted to express my gratitude for the wonderful experience I had at your recent brain disorder conference. As a researcher in the field of neuroscience, I found the conference to be incredibly informative and thought-provoking. The lineup of sp

Brandon Lucke-Wold

University of Florida, USA

l recently attended a brain disorder conference, and I must say it was an incredibly enlightening and informative experience. As someone who has been personally affected by a loved one's brain disorder, I was eager to learn more about the

Santiago Restrepo Garizabal

Universidad de Barcelona, Spain

Overall, I feel that attending this brain disorder conference was a valuable investment of my time and energy. The conference brought together a diverse group of experts, including doctors, researchers, therapists, and caregivers, all with valuabl

Rajendra D. Badgaiyan

Richmond University Medical Center, New York

I recently had the privilege of attending a Brain Disorder Conference, and it was truly an enlightening experience. Another highlight of the conference was the opportunity to network with other attendees, many of whom were also living with or